This is an unofficial archive of PsychonautWiki as of 2025-08-11T15:14:44Z. Content on this page may be outdated, incomplete, or inaccurate. Please refer to the original page for the most up-to-date information.
Template:SubstanceBox/Gabapentin: Difference between revisions
>Josikins Created page with " {{SubstanceBox <!-- Table Properties --> |MaterialTable_MaxWidth=250px |MaterialTable_Title={{PAGENAME}} <!-- Modules --> |ModuleSource=false |Modul..." |
>Isaak Annotate bioavailability correctly |
||
| (42 intermediate revisions by 18 users not shown) | |||
| Line 2: | Line 2: | ||
{{SubstanceBox | {{SubstanceBox | ||
<!-- | <!-- Special Parameters --> | ||
|displayClasses={{{displayClasses|}}} | |||
|MaterialTable_MaxWidth=250px | |MaterialTable_MaxWidth=250px | ||
|MaterialTable_Title={{PAGENAME}} | |MaterialTable_Title={{PAGENAME}} | ||
| Line 11: | Line 12: | ||
|ModuleStructure=true | |ModuleStructure=true | ||
|ModuleNomenclature=true | |ModuleNomenclature=true | ||
|ModuleClassMembership=true | |||
|ModuleROA=true | |ModuleROA=true | ||
| Line 32: | Line 34: | ||
<!-- Structure --> | <!-- Structure --> | ||
|MolecularStructureCaption= | |MolecularStructureCaption=Molecular structure of gabapentin | ||
|SkeletalImageFile=File: | |SkeletalImageFile=File:Gabapentin.svg | ||
|SkeletalImageWidth= | |SkeletalImageWidth=245px | ||
|3DImageFile= | |3DImageFile= | ||
|3DImageWidth= | |3DImageWidth=245px | ||
<!-- Nomenclature --> | <!-- Nomenclature --> | ||
|NameCommon= | |NameCommon=[[common name::Gabapentin]], [[common name::Neurontin]], [[common name::Gabarone]], [[common name::Gralise]] | ||
|NameSubstitution=1-( | |NameSubstitution=Gabapentin | ||
| | |NameSystematic=1-(Aminomethyl)cyclohexaneacetic acid | ||
<!-- Class Membership --> | |||
|EffectClass=[[Depressant]] | |||
|ChemicalClass=[[Gabapentinoid]] | |||
<!-- Dosage/Duration --> | <!-- Dosage/Duration --> | ||
|OralROA=true | |OralROA=true | ||
|OralROA_Collapsed= | |OralROA_Collapsed=false | ||
|OralROA_Caption= | |OralROA_Caption= | ||
|OralROA_Bioavailability=[[Oral min bioavailability::27]]% - [[Oral max bioavailability::60]]%<ref name="NeurotoninMedScape">{{Citation | title=Neurontin, Gralise (gabapentin) dosing, indications, interactions, adverse effects, and more | url=https://reference.medscape.com/drug/neurontin-gralise-gabapentin-343011}}</ref> | |||
|OralROA_Threshold= | |OralROA_Threshold=[[Oral threshold dose::200]] [[Oral dose units::mg]] | ||
|OralROA_Light= | |OralROA_Light=[[Oral min light dose::200]] - [[Oral max light dose::900]] mg | ||
|OralROA_Common= | |OralROA_Common=[[Oral min common dose::900]] - [[Oral max common dose::1500]] mg | ||
|OralROA_Strong= | |OralROA_Strong=[[Oral min strong dose::1500]] - [[Oral max strong dose::2400]] mg | ||
|OralROA_Heavy= | |OralROA_Heavy=[[Oral heavy dose::2400]] mg + | ||
|OralROA_TimelineFile= | |OralROA_TimelineFile= | ||
|OralROA_TimelineWidth= | |OralROA_TimelineWidth= | ||
|OralROA_Duration= | |OralROA_Duration=[[Oral min total time::6]] - [[Oral max total time::10]] [[Oral total time units::hours]] | ||
|OralROA_Onset= | |OralROA_Onset=[[Oral min onset time::30]] - [[Oral max onset time::120]] [[Oral onset time units::minutes]] | ||
|OralROA_Peak= | |OralROA_Peak=[[Oral min peak time::120]] - [[Oral max peak time::180]] [[Oral peak time units::minutes]] | ||
|OralROA_Offset= | |OralROA_Offset= | ||
| | |OralROA_Aftereffects= | ||
}} | }} | ||